ANDREW BOGGS: Open Payments
NPI 1982362182 · HINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $542 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 14 | $288 |
| Alkermes, Inc. | 7 | $238 |
| Vanda Pharmaceuticals Inc. | 7 | $220 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $159 |
| Supernus Pharmaceuticals, Inc. | 3 | $147 |
| ABBVIE INC. | 4 | $84 |
| Tris Pharma Inc | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
Products named: Auvelity, ARISTADA, FANAPT, CAPLYTA, Qelbree, VRAYLAR, Dyanavel XR, AUSTEDO XR.
Industry payments across GA — which companies pay providers there.
